ArticleJournal for immunotherapy of cancer2020

CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma.

Quan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.